NOVARTIS AG (NVSEF)
Clinical trial NCT04573478 updates: 1. completion date: 2026-12-18 → 2028-04-14 2. primary completion date: 2026-12-18 → 2028-04-14
Clinical trial NCT04573478 updates: 1. completion date: 2026-12-18 → 2028-04-14 2. primary completion date: 2026-12-18 → 2028-04-14
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical